LSV ASSET MANAGEMENT 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 3:12 pm Sale |
2023-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
LSV ASSET MANAGEMENT | 6,793,701 4.350% |
-1,132,696 (-14.29%) |
Filing |
| 2023-02-10 4:16 pm Purchase |
2022-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
LSV ASSET MANAGEMENT | 7,926,397 5.170% |
7,926,397 (New Position) |
Filing |